Specifications
Indications
The Nile SIR stent systems are indicated for the treatment of patients with clinical symptoms of myocardial ischemia related to the pathological condition of de novo lesions in native coronary arteries located on bifurcation sites, excluding left main trunk.
| Drug | Sirolimus |
|---|---|
| Polymer | Biodegradable-polymer |
| Dosage | 1.4 µg/mm² |
| Material | Cobalt Chromium Alloy L605 |
|---|---|
| Length | 18 to 24 mm |
| Diameter | See Table in “Ordering information” |
| Number of cells | 7/8/6 or 9/10/8 |
| Metal to artery ratio | From 10 to 15% |
| Stent thickness | 73 µm |
| Nominal pressure | 8 atm |
| Rated Burst Pressure | 14 atm |
| Guidewire compatibility | 0.014" |
| Guiding catheter compatibility | 6F |